VeriMompunica granatum peel extract est-il sûr pendant la grossesse ?
No EU ban/restriction or harmonised CLP reproductive (H360/H361) classification found for Punica granatum peel extract (CAS 84961-57-9) and the Cosmetic Ingredient Review (CIR) evaluated Punica granatum extracts in a safety assessment for cosmetic use. Peer‑reviewed human/placental studies report neutral or protective effects of pomegranate polyphenols rather than teratogenicity. Together these sources do not provide evidence of reproductive hazard for topical cosmetic use. (See CIR safety review; ECHA substance page; placental study).
Pregnancy-safe products containing punica granatum peel extract
Related ingredients
Frequently asked questions
- punica granatum peel extract est-il sûr pendant la grossesse ?
- No EU ban/restriction or harmonised CLP reproductive (H360/H361) classification found for Punica granatum peel extract (CAS 84961-57-9) and the Cosmetic Ingredient Review (CIR) evaluated Punica granatum extracts in a safety assessment for cosmetic use. Peer‑reviewed human/placental studies report neutral or protective effects of pomegranate polyphenols rather than teratogenicity. Together these sources do not provide evidence of reproductive hazard for topical cosmetic use. (See CIR safety review; ECHA substance page; placental study).
- punica granatum peel extract est-il sûr pendant l'allaitement ?
- No data showing breast‑milk mediated infant harm from topical use of pomegranate peel extract and no regulatory bans/restrictions. Lactation resources and clinical studies of maternal pomegranate ingestion show metabolite transfer to milk but not demonstrated toxicity from typical exposures; topical cosmetic use would give substantially lower systemic exposure. (See LactMed summary and CIR review).
- punica granatum peel extract est-il sûr pour la peau de bébé ?
- No evidence of developmental reproductive hazard specific to infants; mechanism data absent. Exposure score increased by +1 for baby skin because infant skin has higher permeability and surface‑area‑to‑weight, and cosmetic ingredients with measurable dermal absorption (polyphenols can be absorbed orally/topically) warrant a conservative higher exposure rating even when adult absorption is low. No infant‑specific adverse data were identified for topical use of pomegranate peel extract.
- Comment VeriMom évalue-t-il punica granatum peel extract ?
- VeriMom évalue punica granatum peel extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à punica granatum peel extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à punica granatum peel extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.